A citation-based method for searching scientific literature

Yuan Zhou, Qian Wang, Qi Yang, Jielin Tang, Chonghui Xu, Dongwei Gai, Xinwen Chen, Jizheng Chen. Virol Sin 2018
Times Cited: 18







List of co-cited articles
73 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Suppressive effect of the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) on hepatitis C virus replication.
Ayami Sato, Yoshimasa Saito, Kazuo Sugiyama, Noriko Sakasegawa, Toshihide Muramatsu, Shinya Fukuda, Mikiko Yoneya, Masaki Kimura, Hirotoshi Ebinuma, Toshifumi Hibi,[...]. J Cell Biochem 2013
29
27

Selective inhibitor of histone deacetylase 6 (tubastatin A) suppresses proliferation of hepatitis C virus replicon in culture of human hepatocytes.
M V Kozlov, A A Kleymenova, K A Konduktorov, A Z Malikova, S N Kochetkov. Biochemistry (Mosc) 2014
16
31

Erasers of histone acetylation: the histone deacetylase enzymes.
Edward Seto, Minoru Yoshida. Cold Spring Harb Perspect Biol 2014
917
16


New and emerging HDAC inhibitors for cancer treatment.
Alison C West, Ricky W Johnstone. J Clin Invest 2014
930
16

Identification of histone deacetylase inhibitors with benzoylhydrazide scaffold that selectively inhibit class I histone deacetylases.
Yunfei Wang, Ryan L Stowe, Christie E Pinello, Guimei Tian, Franck Madoux, Dawei Li, Lisa Y Zhao, Jian-Liang Li, Yuren Wang, Yuan Wang,[...]. Chem Biol 2015
51
16

A replicon-based bioassay for the measurement of interferons in patients with chronic hepatitis C.
Jan M Vrolijk, Artur Kaul, Bettina E Hansen, Volker Lohmann, Bart L Haagmans, Solko W Schalm, Ralf Bartenschlager. J Virol Methods 2003
146
16

Inside HDACs with more selective HDAC inhibitors.
Joëlle Roche, Philippe Bertrand. Eur J Med Chem 2016
185
16

HIV-1 Vpr Protein Induces Proteasomal Degradation of Chromatin-associated Class I HDACs to Overcome Latent Infection of Macrophages.
Bizhan Romani, Nima Shaykh Baygloo, Mojtaba Hamidi-Fard, Mohammad Reza Aghasadeghi, Elham Allahbakhshi. J Biol Chem 2016
29
16

Structural isomers of cinnamic hydroxamic acids block HCV replication via different mechanisms.
Maxim V Kozlov, Konstantin A Konduktorov, Alsu Z Malikova, Kamila A Kamarova, Anastasia S Shcherbakova, Pavel N Solyev, Sergey N Kochetkov. Eur J Med Chem 2019
4
75

Spatiotemporal Coupling of the Hepatitis C Virus Replication Cycle by Creating a Lipid Droplet- Proximal Membranous Replication Compartment.
Ji-Young Lee, Mirko Cortese, Uta Haselmann, Keisuke Tabata, Inés Romero-Brey, Charlotta Funaya, Nicole L Schieber, Yu Qiang, Marie Bartenschlager, Stephanie Kallis,[...]. Cell Rep 2019
54
16

Zinc binding groups for histone deacetylase inhibitors.
Lei Zhang, Jian Zhang, Qixiao Jiang, Li Zhang, Weiguo Song. J Enzyme Inhib Med Chem 2018
99
16

Epigenetic control of HIV-1 post integration latency: implications for therapy.
Amit Kumar, Gilles Darcis, Carine Van Lint, Georges Herbein. Clin Epigenetics 2015
75
11

Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones.
Teresa Pollicino, Laura Belloni, Giuseppina Raffa, Natalia Pediconi, Giovanni Squadrito, Giovanni Raimondo, Massimo Levrero. Gastroenterology 2006
320
11

HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor.
Jeffrey J Kovacs, Patrick J M Murphy, Stéphanie Gaillard, Xuan Zhao, June-Tai Wu, Christopher V Nicchitta, Minoru Yoshida, David O Toft, William B Pratt, Tso-Pang Yao. Mol Cell 2005
848
11


The molecular hallmarks of epigenetic control.
C David Allis, Thomas Jenuwein. Nat Rev Genet 2016
11

PRMT5 restricts hepatitis B virus replication through epigenetic repression of covalently closed circular DNA transcription and interference with pregenomic RNA encapsidation.
Wen Zhang, Jieliang Chen, Min Wu, Xiaonan Zhang, Min Zhang, Lei Yue, Yaming Li, Jiangxia Liu, Baocun Li, Fang Shen,[...]. Hepatology 2017
80
11

Mocetinostat for relapsed classical Hodgkin's lymphoma: an open-label, single-arm, phase 2 trial.
Anas Younes, Yasuhiro Oki, R Gregory Bociek, John Kuruvilla, Michelle Fanale, Sattva Neelapu, Amanda Copeland, Daniela Buglio, Ahmed Galal, Jeffrey Besterman,[...]. Lancet Oncol 2011
127
11

Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function.
Laura Belloni, Teresa Pollicino, Francesca De Nicola, Francesca Guerrieri, Giuseppina Raffa, Maurizio Fanciulli, Giovanni Raimondo, Massimo Levrero. Proc Natl Acad Sci U S A 2009
323
11

Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases.
A Lahm, C Paolini, M Pallaoro, M C Nardi, P Jones, P Neddermann, S Sambucini, M J Bottomley, P Lo Surdo, A Carfí,[...]. Proc Natl Acad Sci U S A 2007
399
11

Structure, mechanism, and inhibition of histone deacetylases and related metalloenzymes.
Patrick M Lombardi, Kathryn E Cole, Daniel P Dowling, David W Christianson. Curr Opin Struct Biol 2011
168
11

Hydroxamic acids block replication of hepatitis C virus.
Teng Ai, Yanli Xu, Li Qiu, Robert J Geraghty, Liqiang Chen. J Med Chem 2015
24
11

The Metabolic Regulator Histone Deacetylase 9 Contributes to Glucose Homeostasis Abnormality Induced by Hepatitis C Virus Infection.
Jizheng Chen, Ning Wang, Mei Dong, Min Guo, Yang Zhao, Zhiyong Zhuo, Chao Zhang, Xiumei Chi, Yu Pan, Jing Jiang,[...]. Diabetes 2015
31
11

Benzohydroxamic acids as potent and selective anti-HCV agents.
Maxim V Kozlov, Alla A Kleymenova, Lyudmila I Romanova, Konstantin A Konduktorov, Olga A Smirnova, Vladimir S Prasolov, Sergey N Kochetkov. Bioorg Med Chem Lett 2013
14
14

Class I HDAC Inhibitors Display Different Antitumor Mechanism in Leukemia and Prostatic Cancer Cells Depending on Their p53 Status.
Xiaoyang Li, Yuri K Peterson, Elizabeth S Inks, Richard A Himes, Jiaying Li, Yingjie Zhang, Xiujie Kong, C James Chou. J Med Chem 2018
36
11

Bicyclic-Capped Histone Deacetylase 6 Inhibitors with Improved Activity in a Model of Axonal Charcot-Marie-Tooth Disease.
Sida Shen, Veronick Benoy, Joel A Bergman, Jay H Kalin, Mariana Frojuello, Giulio Vistoli, Wanda Haeck, Ludo Van Den Bosch, Alan P Kozikowski. ACS Chem Neurosci 2016
49
11

Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A.
Kyle V Butler, Jay Kalin, Camille Brochier, Guilio Vistoli, Brett Langley, Alan P Kozikowski. J Am Chem Soc 2010
513
11

Synthesis and biological evaluation of ortho-aryl N-hydroxycinnamides as potent histone deacetylase (HDAC) 8 isoform-selective inhibitors.
Wei-Jan Huang, Yi-Ching Wang, Shi-Wei Chao, Chen-Yui Yang, Liang-Chieh Chen, Mei-Hsiang Lin, Wen-Chi Hou, Mei-Yu Chen, Tai-Lin Lee, Ping Yang,[...]. ChemMedChem 2012
48
11

HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response.
Nourdine Hamdane, Frank Jühling, Emilie Crouchet, Houssein El Saghire, Christine Thumann, Marine A Oudot, Simonetta Bandiera, Antonio Saviano, Clara Ponsolles, Armando Andres Roca Suarez,[...]. Gastroenterology 2019
130
11


Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity.
Kouichi Miura, Kojiro Taura, Yuzo Kodama, Bernd Schnabl, David A Brenner. Hepatology 2008
200
11

Iron regulator hepcidin exhibits antiviral activity against hepatitis C virus.
Hongyan Liu, Thu Le Trinh, Huijia Dong, Robertson Keith, David Nelson, Chen Liu. PLoS One 2012
36
11

HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase.
Lise Rivière, Laetitia Gerossier, Aurélie Ducroux, Sarah Dion, Qiang Deng, Marie-Louise Michel, Marie-Annick Buendia, Olivier Hantz, Christine Neuveut. J Hepatol 2015
122
11

Histone Deacetylase Inhibitors as Anticancer Drugs.
Tomas Eckschlager, Johana Plch, Marie Stiborova, Jan Hrabeta. Int J Mol Sci 2017
636
11

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
11


Epigenetic modifications and human disease.
Anna Portela, Manel Esteller. Nat Biotechnol 2010
11

Identification of histone deacetylase 3 as a biomarker for tumor recurrence following liver transplantation in HBV-associated hepatocellular carcinoma.
Li-Ming Wu, Zhe Yang, Lin Zhou, Feng Zhang, Hai-Yang Xie, Xiao-Wen Feng, Jian Wu, Shu-Sen Zheng. PLoS One 2010
82
11

HIV-1 Vpr reactivates latent HIV-1 provirus by inducing depletion of class I HDACs on chromatin.
Bizhan Romani, Razieh Kamali Jamil, Mojtaba Hamidi-Fard, Pooneh Rahimi, Seyed Bahman Momen, Mohammad Reza Aghasadeghi, Elham Allahbakhshi. Sci Rep 2016
26
11

Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals.
Shira Perez, Antony Kaspi, Tom Domovitz, Ateret Davidovich, Anat Lavi-Itzkovitz, Tomer Meirson, Jacinta Alison Holmes, Chia-Yen Dai, Chung-Feng Huang, Raymond T Chung,[...]. PLoS Genet 2019
76
11

Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA.
Catherine L Jopling, Minkyung Yi, Alissa M Lancaster, Stanley M Lemon, Peter Sarnow. Science 2005
11

Genetic dissection of Flaviviridae host factors through genome-scale CRISPR screens.
Caleb D Marceau, Andreas S Puschnik, Karim Majzoub, Yaw Shin Ooi, Susan M Brewer, Gabriele Fuchs, Kavya Swaminathan, Miguel A Mata, Joshua E Elias, Peter Sarnow,[...]. Nature 2016
267
11

A genome-wide genetic screen for host factors required for hepatitis C virus propagation.
Qisheng Li, Abraham L Brass, Aylwin Ng, Zongyi Hu, Ramnik J Xavier, T Jake Liang, Stephen J Elledge. Proc Natl Acad Sci U S A 2009
288
11

From non-A, non-B hepatitis to hepatitis C virus cure.
Jean-Michel Pawlotsky, Jordan J Feld, Stefan Zeuzem, Jay H Hoofnagle. J Hepatol 2015
231
11

Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication.
Keril J Blight, Jane A McKeating, Charles M Rice. J Virol 2002
946
11


Dual inhibition of AKT-mTOR and AR signaling by targeting HDAC3 in PTEN- or SPOP-mutated prostate cancer.
Yuqian Yan, Jian An, Yinhui Yang, Di Wu, Yang Bai, William Cao, Linlin Ma, Junhui Chen, Zhendong Yu, Yundong He,[...]. EMBO Mol Med 2018
34
11

Hdac3 is essential for the maintenance of chromatin structure and genome stability.
Srividya Bhaskara, Sarah K Knutson, Guochun Jiang, Mahesh B Chandrasekharan, Andrew J Wilson, Siyuan Zheng, Ashwini Yenamandra, Kimberly Locke, Jia-Ling Yuan, Alyssa R Bonine-Summers,[...]. Cancer Cell 2010
260
11

Validation of histone deacetylase 3 as a therapeutic target in castration-resistant prostate cancer.
Abigail B McLeod, James P Stice, Suzanne E Wardell, Holly M Alley, Ching-Yi Chang, Donald P McDonnell. Prostate 2018
18
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.